Clover Health to go public via merger with SCH

By William Girling
Insurtech Clover Health has announced plans to become a publicly-traded company through a merger with Social Capital Hedosophia (SCH...

Insurtech Clover Health has announced plans to become a publicly-traded company through a merger with Social Capital Hedosophia (SCH).

A move intended to bolster Clover’s national development in the US (it’s currently available in select counties in Arizona, Georgia, Mississippi, New Jersey, Pennsylvania, South Carolina, Tennessee, and Texas), the company hopes that its goal of increasing the quality of health outcomes will be better served. 

“We have made it our business to make healthcare affordable. Our technology helps doctors, leading to better outcomes and lower out-of-pocket expenses for members,” said Andrew Toy, President and Co-Founder. 

Toy emphasised the importance of the company’s data platform (Clover Assistant) and encouraged doctors to make use of it so that they can focus on their true goal: caring for patients.

“Importantly, the platform is powered by a closed feedback loop, linking clinical data and physician action, which improves continuously as membership grows, allowing us to constantly evolve new ways of helping physicians and their patients,” he added.

Developing fast

This news comes soon after Clover’s announced collaboration with Walmart, a project aimed at combining high-quality healthcare with affordable costs to eligible Medicare patients in the state of Georgia (approximately half a million people). 

Despite only forming in 2016, the company’s momentum has been noticeably accelerating; the effect of COVID-19 on the American population is underscoring the need for better health cover and systemic reform. Chamath Palihapitiya, Founder and CEO of SCH, explains further:

“We need companies like Clover to help fix our broken healthcare system. The company’s rapid growth is a testament to the effectiveness of its tech-enabled approach, which resonates powerfully with consumers and physicians alike. 

“I believe Clover is uniquely positioned to disrupt the entire Medicare Advantage market as well as expand into new and exciting opportunities in Original Medicare. I am proud to partner with Vivek [Garipalli, CEO and Co-Founder of Clover Health], Andrew and the entire Clover team on the next phase of their mission to improve lives across the country.”


Featured Articles

Insurtech unicorn bolttech takes on extra $50m in funding

Insurtech unicorn bolttech has taken on an extra US$50m in funding from Leapfrog Investments as part of the insurtech's Series B extension

Allianz wants to 'lead by example' with new net-zero targets

Allianz has said it wants to "lead by example" after announcing ambitious new targets to make its investment and underwriting portfolios net zero

Insurtech pricing solution Akur8 seals $25m in fresh funding

Akur8, whose insurtech solution is used by actuaries to build pricing models across all insurance lines, has received backing from Guidewire and FinTLV

Beazley launches tornado parametric insurance using NWS data


Alex Dalyac: Founding AI-based insurtech Tractable

Technology & AI

Saudi Arabia: 'solid' framework to guide insurtech sector